Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Operating Profit Margin since 2005
- Debt to Equity since 2005
- Price to Earnings (P/E) since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Debt
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Free Cash Flow to Equity (FCFE)
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
Item | Description | The company |
---|---|---|
FCFE | Free cash flow to equity is the cash flow available to Medtronic PLC equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made. | Medtronic PLC FCFE decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level. |
Price to FCFE Ratio, Current
No. shares of common stock outstanding | |
Selected Financial Data (US$) | |
Free cash flow to equity (FCFE) (in millions) | |
FCFE per share | |
Current share price (P) | |
Valuation Ratio | |
P/FCFE | |
Benchmarks | |
P/FCFE, Competitors1 | |
Abbott Laboratories | |
Cigna Group | |
CVS Health Corp. | |
Elevance Health Inc. | |
Humana Inc. | |
Intuitive Surgical Inc. | |
UnitedHealth Group Inc. | |
P/FCFE, Sector | |
Health Care Equipment & Services | |
P/FCFE, Industry | |
Health Care |
Based on: 10-K (reporting date: 2024-04-26).
1 Click competitor name to see calculations.
If the company P/FCFE is lower then the P/FCFE of benchmark then company is relatively undervalued.
Otherwise, if the company P/FCFE is higher then the P/FCFE of benchmark then company is relatively overvalued.
Price to FCFE Ratio, Historical
Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | ||
---|---|---|---|---|---|---|---|
No. shares of common stock outstanding1 | |||||||
Selected Financial Data (US$) | |||||||
Free cash flow to equity (FCFE) (in millions)2 | |||||||
FCFE per share3 | |||||||
Share price1, 4 | |||||||
Valuation Ratio | |||||||
P/FCFE5 | |||||||
Benchmarks | |||||||
P/FCFE, Competitors6 | |||||||
Abbott Laboratories | |||||||
Cigna Group | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Humana Inc. | |||||||
Intuitive Surgical Inc. | |||||||
UnitedHealth Group Inc. | |||||||
P/FCFE, Sector | |||||||
Health Care Equipment & Services | |||||||
P/FCFE, Industry | |||||||
Health Care |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 Data adjusted for splits and stock dividends.
3 2024 Calculation
FCFE per share = FCFE ÷ No. shares of common stock outstanding
= ÷ =
4 Closing price as at the filing date of Medtronic PLC Annual Report.
5 2024 Calculation
P/FCFE = Share price ÷ FCFE per share
= ÷ =
6 Click competitor name to see calculations.
Valuation ratio | Description | The company |
---|---|---|
P/FCFE | Price to free cash flow to equity is cash valuation indicator of stockholders’ equity. | Medtronic PLC P/FCFE ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024. |